J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
7th April 2022Read More
14th January 2022Read More
J+D were approached by a global pharmaceutical company who needed a new forecasting solution with a robust process management system to give them a solid foundation when forecasting their pipeline assets.
21st October 2021Read More
The adoption of Onco+ has helped this biotech cut the forecast development pipeline significantly and supported best practice forecasting within their team.
23rd April 2021Read More
The background. In this case study, we showcase our latest work with one of Europe’s largest, leading biotechnology pioneers, helping to facilitate better, more collaborative forecasting for hundreds of colleagues across the continent. For the company’s most recent forecasting cycle, our experts have worked to…
J+D Forecasting strike the balance between simplicity and complexity when modelling for the liquid tumour market12th August 2020
The Challenge Identify a clear, transparent, and logical way to structure a forecast model to identify the potential for a new therapy in leukaemia. The model would be complex because patients go through different stages of treatment within a single line of treatment (for example,…
23rd July 2020Read More
One of the world’s first global biotechnology companies a leader, in innovative scientific research in neurological diseases approached J+D Forecasting with a set of forecasting challenges.